Fennec Pharmaceuticals (FENC) Prepaid Assets (2010 - 2025)
Fennec Pharmaceuticals (FENC) posted Prepaid Assets of $1.7 million for Q4 2025, up 23.73% on a QoQ basis from $1.4 million in Q3 2025, and down 43.8% year-over-year from $3.1 million in Q4 2024.
Fennec Pharmaceuticals (FENC) Prepaid Assets (2010 - 2025) Analysis & Trends
Fennec Pharmaceuticals' Prepaid Assets history runs 16 years deep, the most recent figure standing at $1.7 million for Q4 2025.
- Quarterly Prepaid Assets fell 43.8% year-over-year to $1.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.7 million (down 43.8% YoY) and the FY2025 annual result came in at $1.7 million, down 43.8% from the prior year.
- Prepaid Assets was $1.7 million for Q4 2025 at Fennec Pharmaceuticals, up from $1.4 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $3.1 million in Q4 2024 and bottomed at $32000.0 in Q1 2023.
- A 5-year average of $1.0 million and a median of $867500.0 in 2022 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2021 — Prepaid Assets soared 30850.0% — and 2023, when it tumbled 95.52%.
- Fennec Pharmaceuticals' Prepaid Assets stood at $1.0 million in 2021, then declined by 25.53% to $770000.0 in 2022, then jumped by 234.42% to $2.6 million in 2023, then rose by 19.61% to $3.1 million in 2024, then slumped by 43.8% to $1.7 million in 2025.
- Business Quant data shows FENC's Prepaid Assets at $1.7 million in Q4 2025, $1.4 million in Q3 2025, and $965000.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Fennec Pharmaceuticals | 346.75 Mn | 309.97 Mn | 12.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.73 Mn |
| Sep 30, 2025 | 1.40 Mn |
| Jun 30, 2025 | 965,000.00 |
| Mar 31, 2025 | 1.00 Mn |
| Dec 31, 2024 | 3.08 Mn |
| Sep 30, 2024 | 3.07 Mn |
| Jun 30, 2024 | 283,000.00 |
| Mar 31, 2024 | 161,000.00 |
| Dec 31, 2023 | 2.58 Mn |
| Sep 30, 2023 | 1.20 Mn |
| Jun 30, 2023 | 32,000.00 |
| Mar 31, 2023 | 32,000.00 |
| Dec 31, 2022 | 770,000.00 |
| Sep 30, 2022 | 123,000.00 |
| Jun 30, 2022 | 490,000.00 |
| Mar 31, 2022 | 715,000.00 |
| Dec 31, 2021 | 1.03 Mn |
| Sep 30, 2021 | 1.23 Mn |
| Jun 30, 2021 | 409,000.00 |
| Mar 31, 2021 | 619,000.00 |